Galectin Therapeutics Inc posts annual revenue of $52,000 in 2022
Key fundamental financials- loss of $38.78 million
- Revenue of $52,000
By USInMinutes
Published - Apr 05, 2023, 05:29 AM ET
Last Updated - Jul 18, 2023, 04:03 PM EDT
Galectin Therapeutics Inc [GALT] has reported $38.78 million loss for the fiscal year ending Dec 31, 2022.
Revenue for the year was $52,000 .
The Newton, Georgia (GA)-based company operating in the pharmaceutical preparations sector with 12 employees has total shareholders equity of $33,917 million.
Also read:
This is a developing story. Click here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts here.
Our Offices
10kInfo, Inc.
13555 SE 36th St
Bellevue, WA 9800610kInfo Data Solutions, Pvt Ltd.
Claywork Create
11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
Bengaluru, Karnataka 560076
4.2 12182024
Popular News
